Updated NICE multiple sclerosis clinical guideline

June 28, 2022 | Southmedia

The MS Trust summarise the key points of the updated guideline

NICE has recently published the updated Clinical Guideline Multiple sclerosis in adults: management

It gives recommendations on how healthcare and other professionals should care for and support people with MS. The MS Trust have responded to this updated guideline.

Some of the key points include:

  • Extra detail has been added to recommendations throughout the guideline, for example for people who are thinking about starting or extending their family. A new section provides information and support for people whose MS is becoming more advanced. 
  • More healthcare roles have been recommended for MS teams
  • Expanded guidance on non-pharmacological treatments for fatigue.
  • Fampyra has not been approved despite responses to the draft scope from the MS Trust and other MS organisations highlighting the experiences of people who have taken this treatment. 
  • The MS Trust are concerned that NICE has recommended drug treatments for fatigue based on very limited clinical evidence

More information about the update and the responses to it can be found on the MS Trust website

Scroll to Top
Skip to content